닫기
검색

Leadership

Sang Gyu Park
Sang Gyu ParkFounder & CEO
Sang Gyu is the founder and CEO of Novelty Nobility and a senior scientist with 25 years of experience in protein and antibody research. Up to now, he has designed more than 200 antibodies and achieved hands-on knowhow in immunization and affinity maturation, which became the impetus of Novelty Nobility’s pipeline development. Sang Gyu is an incumbent professor of Pharmacy at Ajou University and received a Ph.D. in Pharmacy from Seoul National University. He currently serves as an editorial board member of Scientific Reports.
Jin Cho
Jin ChoChief Finance & Business Officer
Jin leads finance and business activities at Novelty Nobility. He is an experienced professional in fundraising, deal making and operations at a biotech company and is skillful at translating science into business, and vice versa. At Novelty Nobility, Jin is mostly interested in building a corporate culture that woos talented and decent people, while he himself spends most of the time in crunching numbers and reviewing contracts. He received an MBA from MIT Sloan School of Management.
Jung Tae Lee
Jung Tae LeeChief Scientific Officer
Jung Tae is an expert in biologics formulation research and an industry veteran with more than 20 years in research and development of antibody and stem-cell therapeutics. During his 20+ year professional career, he has been responsible for the design, research and development of novel antibody therapeutics and biosimilar products at Hanwha Chemical and additional mid-sized biotech companies. Jung Tae received his Ph.D. in Pharmacy from Sungkyunkwan University.
Suk Bong Hwang
Suk Bong HwangHead Of General Administration
Sukbong began his career in accounting in the mid 90’s and since then has worked for 25 years in general administration. He has accumulated hands-on general operation experience in many companies from start-ups to mid-sized manufacturing companies and feels rewarded through supporting the company's business successes. Trust and responsibility are his lifetime motto, and he is equipped with fatigueless physical strength and unbreakable mental health. No one has ever beaten him in drinking and golf yet.
Jeong Soon Park
Jeong Soon ParkHead of CMC
Jeongsoon leads CMC (Chemistry, Manufacturing and Controls) and biologics manufacturing project management at Novelty Nobility. With more than two decades of industry experience, she has gained a comprehensive understanding of the entire process of biologics manufacturing and development, from cell line development to commercial manufacturing, as well as project management skills to effectively work with external CDMO partners. She previously worked as a principal scientist in process development and open innovation at Samsung Bioepis, and as a research scientist at Progen, a biotech startup spun off from Dong-A ST.  
Sol Han
Sol HanHead of Clinical Development
Sol is a global clinical development expert with 15 years of proven trajectory records at Roche, GSK and most recently Sanofi where she successfully led several clinical trials as a global leader representing the Asia Pacific region. She currently oversees Novelty Nobility’s preclinical, regulatory, and clinical development initiatives, with strong leadership and an ability to coordinate cooperation amongst team members. A licensed pharmacist, Sol majored in Pharmacy at Ewha Womans University and completed her master's degree in drug delivery systems from the same university.
Sung Tae Kim
Sung Tae KimHead of Basic Research
Sung Tae spearheads Novelty Nobility’s basic scientific research covering target discovery and validation, modality design, mechanism of action, and in vivo proof of concept. His long-term research goal is to find novel mechanism-based biologics and develop therapeutic strategies for preventing the onset or progression of various human disorders. He believes that active communication and open discussion with colleagues, which stimulate their passion and ignite scientific curiosity, are indispensable for the success of any project. Sung Tae received his Ph.D. in Pharmaceutical Sciences from the University of Pittsburgh School of Pharmacy and conducted postdoctoral research at the Brigham and Women’s Hospital & Harvard Medical School before joining Novelty Nobility. 
Garam Back
Garam BackHead of Intellectual Property
Garam is a patent attorney who is responsible for all aspects of the company’s intellectual property functions at Novelty Nobility. She has gained a wide range of IP-related experiences in the pharmaceutical field, from prosecution to enforcement to regulatory or legal issues. Drawing from this experience, her work at Novelty Nobility focuses on creating IP strategies and evaluating license/ legal contracts. Before joining the company, Garam worked at Kim & Chang, Yulchon, Law Offices GURU, and other locations for 15 years. She received a bachelor’s degree in Pharmacy from Seoul National University and is a licensed pharmacist.
Arlo McGinn
Arlo McGinnChief Operating Officer, Novelty Nobility USA
Arlo directs business development and operations for Novelty Nobility’s US headquarters in Boston, Massachusetts. A chemist and PhD pharmacologist by training, Arlo has blended his science background with an entrepreneurial spirit to start and build several biotech companies over his 20-year career. His experience has included working with products across the entire development cycle from the R&D bench all the way to NDA submission readiness and commercial sale. Outside the office Arlo enjoys biking, hiking, and exploring New England with his wife and two daughters.